Strategy
A round-up of the latest consumer health industry appointments: GSCF elects chair; Kenvue hires Northern Europe head; Barentz names chief commercial officer.
Galenica outpaced the growth of the OTC market at home, while recording a double-digit gain abroad, to drive up its consumer health product sales in 2024.
Alliance shareholders overwhelmingly back takeover by DBAY Advisors after improved offer values UK-based firm at £362m.
Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.
HBW Insight catches up with Maxwellia CEO Anna Maxwell to discuss her company's journey so far, and what she sees as the opportunities for Rx-to-OTC switch in UK women's health and beyond.
Consumer uptake of Eroxon - the first FDA-approved OTC ED treatment available in the US - has been slower than expected, according to Haleon, which says its working with retailers to build awareness.
The Swedish firm is plotting the path towards launching its ColdZyme virus-blocking spray in China and Japan, while efforts are also underway to find a partner for the North American market.
Venture capital fund backed by Germany's Schwabe has €100m to invest in consumer health startups operating in categories such as sleep and mental health.
Navamedic is seeing good early sales for OTC ED treatment Eroxon in multiple Nordic markets after investing in a marketing push which includes a Mission Impossible-inspired commercial.
UK-based Alliance Pharma reported a single-digit drop in Consumer Healthcare turnover ahead of a shareholder vote on the company's future ownership.
A round-up of the latest exec moves: Haleon names new Southeast Asia head; Reckitt appoints Central Europe chief; and Midsona CEO to depart.
Increased openness about sexual health and wellness, Rx-to-OTC switches and NPD at leading companies, and easy access to products online are driving the growth of Europe's sexual health market, according to Euromonitor International.
HBW Insight asks consumer health experts for their views on the trends that will shape the market in 2025.
A round-up of the latest consumer health exec moves: Haleon names UK head; Kenvue appoints skin health president for APAC & LATAM; Piramal CH hires India CEO.
Successful study results, combined with encouraging market data, prompts Futura Medical to move forward with plans to commercialize a new OTC treatment for sexual dysfunction in women. To map out the path to a US launch, the firm has already held early discussions with the FDA.
Major Europe-based consumer health players Haleon, Bayer and Reckitt feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q4 2024 results over the coming weeks.
A round-up of the latest European people moves: PAGB names new president; Enzymatica hires marketing & sales director; Marinomed strengthens supervisory board.
Bayer Consumer Health, the Global Self-Care Federation and the Business Council for International Understanding outline in a paper how industry can work with multilateral organizations, governments, financial institutions, and stakeholders to "recognize and champion self-care as a fundamental driver of global health progress."
Offer valuing struggling UK consumer health player Alliance at £350m has the backing of the company's board of directors.
Stada has made the strongest indication yet that it is preparing for an initial public offering, appointing Andreas Fibig as independent chairman of a board of directors that will be established “in the event of an IPO.”